Joslin Researcher Identifies Inflammatory Pathway That Offers VEGF-Independent Target for Diabetic Macular Edema Drugs
Research in the lab of Edward P. Feener, Ph.D., Investigator in the Section on Vascular Cell Biology and Director of the Proteomics Core at Joslin Diabetes Center and an Associate Professor of Medicine at Harvard Medical School, now has shown that a...
19-May-2015 10:05 AM EDT
Joslin researchers have uncovered the action of a gene that regulates the education of T cells, providing insight into how and why the immune system begins mistaking the body’s own tissues for targets.
12-May-2015 1:05 PM EDT
Joslin Research Sheds Light on Type 1 Diabetes-Specific Risk Factors in Cardiovascular Disease (CVD)
Research led by Joslin Diabetes Center's Myra Lipes, MD, has identified one culprit in heart failure—an autoimmune reaction triggered by heart attacks. In a recent Current Diabetes Reports paper, Dr. Lipes and her colleague Alfonso Galderisi...
30-Apr-2015 10:05 AM EDT
Joslin Diabetes Center and Daegu-Gyeongbuk Free Economic Zone (DGFEZ) have signed a memorandum of understanding (MOU) formalizing their mutual strong commitment to navigate avenues for potential partnership.
12-Mar-2015 11:05 AM EDT
Joslin Partners with Sunshine Insurance Group Corporation to Develop a Diabetes Center of Excellence in China
Joslin Diabetes Center and Sunshine Insurance Group Corporation Limited have announced today that they are collaborating to design and develop a Diabetes Center of Excellence in Weifang, Shandong Province, China.
10-Mar-2015 10:05 AM EDT
Joslin and Johnson & Johnson Announce New Partnership to Improve Diabetes Management in China Hospitals
Joslin Diabetes Center announced today that they have entered into a partnership with Johnson and Johnson Medical (Shanghai) Co. Ltd (hereafter, JJMS) to improve glycemic control for people with diabetes who are hospitalized in Chinese hospitals.
5-Mar-2015 2:05 PM EST
People with diabetes are more prone to anxiety and depression than those with other chronic diseases that require similar levels of management.
2-Mar-2015 11:05 AM EST
Joslin Researchers Conduct First Trial Directly Comparing Drugs for Diabetic Macular Edema and Find All are Effective
In the first clinical trial directly comparing three drugs most commonly used to treat diabetic macular edema, researchers found all were effective in improving vision and preventing vision loss. However, one drug, aflibercept, provided greater...
19-Feb-2015 8:00 AM EST
Dr. Lori Laffel, Chief of Pediatrics at Joslin Diabetes Center, Available to Comment on Type 1 Diabetes and Life Expectancy Studies
6-Jan-2015 11:00 AM EST
Lori Laffel, M.D., MPH, Chief of the Pediatric, Adolescent and Young Adult Section at Joslin Diabetes Center and Associate Professor of Pediatrics at Harvard Medical School, oversees the largest pediatric diabetes clinic in New England has over 25...
15-Aug-2014 8:00 AM EDT
13-Nov-2013 1:00 PM EST
The International Diabetes Federation now recommends that surgery be considered as a treatment for obese patients with type 2 diabetes. Dr. Allison Goldfine, head of clinical research at Joslin Diabetes Center, is available for comment.
29-Mar-2011 9:00 AM EDT
Emerging technologies such as continuous glucose monitoring (CGM) are helping people with type 1 diabetes manage their condition—what are the next steps? Howard Wolpert, M.D., of Joslin Diabetes Center discusses his current research and the global...
1-Oct-2010 1:00 PM EDT